Co-authored by Ruth Fisher, PhD

The following post explores the bioavailability and efficacy of various cannabis products, followed by a brief overview of the legal protection afforded to each as an intellectual property asset.

Over the millennia, our bodies have evolved to better protect themselves. Protection from outside our bodies comes from our skin, which

Federal agencies recognize that what was once treated as an intangible asset—that is, how “green” a company or its products may be—has developed into a true value-add.  A year ago, the Federal Trade Commission (FTC) announced that as a part of its modified ten-year regulatory review schedule, it would be reviewing and revising its